Joseph C. Papa
Net Worth

Last updated:

What is Joseph C. Papa net worth?

The estimated net worth of Mr. Joseph C. Papa is at least $40,241,884 as of 10 May 2022. He owns shares worth $6,581,884 as insider and has received compensation worth at least $33,660,000 in Bausch Health Companies Inc..

What is the salary of Joseph C. Papa?

Mr. Joseph C. Papa salary is $3,740,000 per year as Chief Executive Officer & Chairman in Bausch Health Companies Inc..

How old is Joseph C. Papa?

Mr. Joseph C. Papa is 69 years old, born in 1956.

What stocks does Joseph C. Papa currently own?

As insider, Mr. Joseph C. Papa owns shares in one company:

Company Title Shares Price per share Total value
Bausch Health Companies Inc. (BHC) Chief Executive Officer & Chairman 839,601 $7.84 $6,581,884

What does Bausch Health Companies Inc. do?

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Joseph C. Papa insider trading

Bausch Health Companies Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Shares, No Par Value 183,522 N/A N/A
Option
Common Shares, No Par Value 65,911 N/A N/A
Option
Restricted Share Units 65,911 $9.4 $619,563
Option
Common Shares, No Par Value 116,697 N/A N/A
Option
Restricted Share Units 208,231 $24.35 $5,070,425
Option
Common Shares, No Par Value 208,231 N/A N/A
Option
Restricted Share Units 317,089 N/A N/A
Option
Common Shares, No Par Value 317,089 N/A N/A
Purchase
Common Shares, No Par Value 30,000 $23.31 $699,300
Purchase
Common Shares, No Par Value 30,000 N/A N/A
Purchase
Common Shares, No Par Value 30,000 N/A N/A
Purchase
Common Shares, No Par Value 30,000 $16.05 $481,500
Purchase
Common Shares, no par value 202,000 $24.48 $4,944,960